Thrombotic microangiopathy ( TMA ) is a complication that developed in some patients receiving 12 Gy total body irradiation ( TBI ) in addition to lymphodepleting preparative chemotherapy prior to infusion of autologous tumor-infiltrating lymphocytes ( TIL ) with high-dose aldesleukin ( IL-2 ) .